Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.10
+3.24 (1.58%)
AAPL  261.95
+1.37 (0.53%)
AMD  199.46
-3.91 (-1.93%)
BAC  52.59
-0.18 (-0.33%)
GOOG  314.80
+11.24 (3.70%)
META  655.49
+10.71 (1.66%)
MSFT  396.65
-1.81 (-0.45%)
NVDA  188.22
+0.32 (0.17%)
ORCL  147.96
-8.58 (-5.48%)
TSLA  407.15
-4.56 (-1.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.